Rare genetic variants in leber hereditary optic neuropathy: molecular mechanisms, diagnosis, and emerging therapies

Hereditary optic neuropathies, such as Leber’s hereditary optic neuropathy (LHON), remain a focus of active research. Diagnostic challenges and severe clinical consequences often result in atypical presentations, creating significant obstacles for neuro-ophthalmology. The field has garnered increased attention due to advances in molecular biology and genetic engineering. Pathogenic variants in mitochondrial DNA (mtDNA) and nuclear DNA disrupt oxidative phosphorylation, reduce adenosine…

Migraine in mitochondrial diseases and disorders: a bioenergetic perspective

Migraine is a neurological disorder increasingly recognized as involving systemic and neuronal bioenergetic vulnerability – a state marked by cellular energy disruption, impaired mitochondrial function, and reduced ATP-generating capacity. Accumulating evidence implicates mitochondrial dysfunction and impaired oxidative phosphorylation as contributors to migraine pathophysiology, linking cellular energy deficits to cortical spreading depression, trigeminovascular activation, and oxidative…

Sterile inflammation in LHON: mitochondrial stress, innate immune signaling, and implications for AAV gene therapy

Leber hereditary optic neuropathy (LHON) is a mitochondrial disease caused primarily by pathogenic mitochondrial DNA (mtDNA) variants that impair respiratory chain complex I function. Although bioenergetic failure, oxidative stress, and retinal ganglion cell degeneration are central features of disease pathogenesis, these mechanisms do not fully explain the incomplete penetrance, male predominance, and marked clinical heterogeneity observed in LHON. Emerging evidence suggests that mitochondrial…